Real-Life Results of the Extended Longevity Protocol
Welcome back to our Extended Longevity series! Today, we will be discussing the real-life results of using the Extended Longevity Protocol on several individuals whose Epigenome Tests, Telomere Tests, and C-RP tests have been published on our results page.
As a quick refresher, the Extended Longevity Protocol consists of a set of 10 Phytotherapeutic Extract Formulations that address the 10 determinant factors of aging. These formulations work synergistically to enhance cellular and metabolic efficiency, reduce inflammation, regenerate tissues, and extend lifespan.
Now, let's dive into the results.
First, let's talk about Steven. He is a 69-year-old man who had a baseline Epigenome Test score of 67 when he was 66, before starting the Extended Longevity Protocol. After twelve months of use, his Epigenome Test score improved to 53, a 14 year biological age deceleration. In addition, his Telomere Test score improved to 9,010 base pairs, indicating an improvement in cellular aging. Recently, his telomere had grown to 10,380 bp, a state of hyper long telomeres, which are longer than a newborn. Lastly, his Hs C-RP test improved to 0.5, indicating a low and desirable amount of inflammation.
Next, let's look at Kimberly. Kimberly is a 58-year-old woman who had an initial Epigenome Test score of 60 before starting the Extended Longevity Protocol. After six months of use, her Epigenome Test score improved to 46, a 14-year biological age deceleration. Her Telomere Test score improved from 6,700 bp to 7,020 bp, and her Hs C-RP test improved from 0.8 to 0.2. Finally, let's examine Sky. He is a 75-year-old man who had an Epigenome Test score of 62 years old biological age. His recent epigenome test at 76 is 65 years old, maintaining an eleven year biological deceleration. His Telomere Test was 9,300 bp, the equivalent of a 10-year old and his C-RP test improved from 2 to 0.6
These results demonstrate the potential of the Extended Longevity Protocol to improve the health and wellbeing of individuals as they age. The improvements seen in the Epigenome Test scores indicate a reversal of epigenetic age, which has been linked to numerous age-related diseases. The improvements in Telomere Test scores indicate an improvement in cellular aging, while the improvements in C-RP tests indicate a reduction in inflammation, which has also been linked to various age-related diseases.
In conclusion, the Extended Longevity Protocol has shown significant results in real-life individuals. By addressing the 10 determinant factors of aging, this protocol has the potential to extend lifespan and improve health and wellbeing as we age.